Maxie Gordon, MD
Psychiatry · Clinton, MSNPI 1427018613
Payments from drug & device makers
Across 1,743 payments — averaging $753.27 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$534K
- Neurocrine Biosciences, Inc.$359K
- Johnson & Johnson$208K
- Alkermes, Inc.$150K
- Teva Pharmaceuticals USA, Inc.$25K
- Sunovion Pharmaceuticals Inc.$18K
- plus $18K from 17 others
Across 1 payment — averaging $18,750 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Pfizer$19K
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 552 | $534,491 |
| Neurocrine Biosciences, Inc. | 422 | $358,994 |
| Johnson & Johnson | 286 | $207,881 |
| Alkermes, Inc. | 165 | $150,368 |
| Teva Pharmaceuticals USA, Inc. | 51 | $24,846 |
| Sunovion Pharmaceuticals Inc. | 37 | $18,326 |
| Vanda Pharmaceuticals Inc. | 44 | $9,694 |
| Pfizer | 2 | $3,327 |
| Neuronetics, Inc. | 5 | $1,599 |
| AbbVie(2 entities) | 67 | $1,060 |
| Lundbeck LLC | 45 | $654 |
| Otsuka America Pharmaceutical, Inc. | 18 | $441 |
| Janssen Scientific Affairs, LLC | 4 | $374 |
| Indivior Inc. | 16 | $273 |
| Axsome Therapeutics, Inc. | 6 | $185 |
| Takeda Pharmaceuticals U.S.A., Inc. | 9 | $160 |
| E.r. Squibb & Sons, L.L.C. | 5 | $100 |
| Livanova USA, Inc. | 2 | $69 |
| Avanir Pharmaceuticals, Inc. | 3 | $42 |
| Shire North American Group Inc | 1 | $23 |
| Ironshore Pharmaceuticals Inc. | 1 | $17 |
| Boston Scientific | 1 | $16 |
| Tris Pharma Inc | 1 | $13 |
How this compares
$1,312,953 in reported general payments places this provider in the 95th percentile of 219 psychiatry providers in Mississippi.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other psychiatry in Clinton
- Joseph KwentusFlowood$5M
- Kurt BuechlerRidgeland$1.1M
- Chasity TorrenceWhitfield$834K
- Jon JacksonJackson$834K
- Clyde GlennRidgeland$231K
- John NortonJackson$173K
- Amy MillerSaltillo$82K
- Krishan GuptaJackson$26K
- Andrew BishopJackson$21K
- Mark WebbRidgeland$12K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.